AIP
CELG

ARS Investment Partners’s Celgene Corp CELG Stock Holding History

ARS Investment Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-124,544
Closed -$11.7M – 143
2019
Q1 		$11.7M Buy
+124,544
New +$10.9M 2.13% 16
2018
Q4 		– Sell
-135,137
Closed -$12.1M – 125
2018
Q3 		$12.1M Buy
135,137
+79,073
+141% +$6.99M 1.87% 19
2018
Q2 		$4.45M Buy
56,064
+31,893
+132% +$2.65M 0.71% 36
2018
Q1 		$2.16M Sell
24,171
-35,102
-59% -$3.37M 0.26% 65
2017
Q4 		$6.19M Sell
59,273
-12,865
-18% -$1.45M 0.75% 41
2017
Q3 		$10.5M Buy
72,138
+39,204
+119% +$5.34M 1.36% 28
2017
Q2 		$4.28M Buy
32,934
+31,151
+1,747% +$3.82M 0.59% 47
2017
Q1 		$222K Buy
+1,783
New +$213K 0.03% 149

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

ARS Investment Partners's CELG Position: Q2 2019 in Review

ARS Investment Partners sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 124,544 shares — an estimated $11.7M sold.

ARS Investment Partners first reported a position in CELG in Q1 2017 and held it in 8 quarters. The position peaked at $12.1M in Q3 2018. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • ARS Investment Partners reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • ARS Investment Partners sold 124,544 Celgene Corp shares in Q2 2019, an estimated $11.7M.
  • ARS Investment Partners first reported a position in Celgene Corp in Q1 2017 and held it in 8 quarters.
  • ARS Investment Partners's Celgene Corp position peaked at $12.1M in Q3 2018.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on ARS Investment Partners's 13F filing for Q2 2019, filed 12 Aug 2019.